BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7276210)

  • 1. Assay of serum immunoreactive trypsin in dried blood spots and the early detection of cystic fibrosis.
    Ryley HC; Robinson PG; Yamashiro Y; Bradley DM
    J Clin Pathol; 1981 Aug; 34(8):906-10. PubMed ID: 7276210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal screening for cystic fibrosis, using immunoreactive trypsin assay in dried blood spots.
    Crossley JR; Smith PA; Edgar BW; Gluckman PD; Elliott RB
    Clin Chim Acta; 1981 Jun; 113(2):111-21. PubMed ID: 7249357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a dried blood spot in immunoreactive-trypsin assay for detection of cystic fibrosis in infants.
    Kirby LT; Applegarth DA; Davidson AG; Wong LT; Hardwick DF
    Clin Chem; 1981 May; 27(5):678-8. PubMed ID: 7226492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a screening system for cystic fibrosis: meconium or blood spot trypsin assay or both?
    Pederzini F; Faraguna D; Giglio L; Pedrotti D; Perobelli L; Mastella G
    Acta Paediatr Scand; 1990 Oct; 79(10):935-42. PubMed ID: 2124772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mucoviscidosis screening by determination of immunoreactive trypsin].
    Sander J; Niehaus C
    Klin Padiatr; 1984; 196(4):224-7. PubMed ID: 6482307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunoreactive trypsin in the serum of normal children and children with gastrointestinal diseases].
    Dockter G; Steyns M; Biro G; Sitzmann FC
    Monatsschr Kinderheilkd; 1984 Aug; 132(8):589-93. PubMed ID: 6482880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the diagnostic value of serum pancreatic isoamylase and immunoreactive trypsin measurement in patients with cystic fibrosis.
    Brown RC; Chalmers DM; Rowe VL; Kelleher J; Littlewood JM; Losowsky MS
    J Clin Pathol; 1982 May; 35(5):547-9. PubMed ID: 7085899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum immunoreactive trypsin in cystic fibrosis.
    Dandona P; Hodson M; Bell J; Ramdial L; Beldon I; Batten JC
    Thorax; 1981 Jan; 36(1):60-2. PubMed ID: 7292384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal screening for cystic fibrosis: a comparison of two strategies for case detection in 1.2 million babies.
    Wilcken B; Wiley V; Sherry G; Bayliss U
    J Pediatr; 1995 Dec; 127(6):965-70. PubMed ID: 8523199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystic fibrosis screening by dried blood spot trypsin assay: results in 75,000 newborn infants.
    Wilcken B; Brown AR; Urwin R; Brown DA
    J Pediatr; 1983 Mar; 102(3):383-7. PubMed ID: 6827410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoreactive trypsin on dried-blood spots as a possible neonatal test for cystic fibrosis. (I. Evaluation of the method and preliminary field trial).
    Dominici R; Monaco F; Morano S; Antonozzi I
    Ric Clin Lab; 1980; 10(3):511-9. PubMed ID: 6999590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactive trypsin levels in neonates with meconium ileus.
    Steven LC; Gavel G; Young D; Carachi R
    Pediatr Surg Int; 2006 Mar; 22(3):236-9. PubMed ID: 16395608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive trypsin assay for dried-blood specimens as a screening procedure for early detection of cystic fibrosis.
    King DN; Heeley AF; Walsh MP; Kuzemko JA
    Lancet; 1979 Dec; 2(8154):1217-9. PubMed ID: 92625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mucoviscidosis screening with immunoreactive trypsin].
    Eber E; Ellemunter H; Engele H; Götz M; Grünberger W; Haas J; Janisch H; Leodolter S; Litscher H; Müller G
    Wien Klin Wochenschr; 1992; 104(22):681-5. PubMed ID: 1475973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dried-blood spot screening for cystic fibrosis in the newborn.
    Crossley JR; Elliott RB; Smith PA
    Lancet; 1979 Mar; 1(8114):472-4. PubMed ID: 85057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behaviour of serum immunoreactive trypsin after serum activation by enterokinase in normal and cystic fibrosis patients. Evidence of a trypsin-alpha 1-proteinase inhibitor complex in some cystic fibrosis patients.
    Carrère J; Chazalette JP; Figarella C
    Biochim Biophys Acta; 1989 Dec; 993(2-3):137-42. PubMed ID: 2480820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for cystic fibrosis in dried blood spots of newborns.
    Audrézet MP; Costes B; Ghanem N; Fanen P; Verlingue C; Morin JF; Mercier B; Goossens M; Férec C
    Mol Cell Probes; 1993 Dec; 7(6):497-502. PubMed ID: 8145780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal screening for cystic fibrosis in Wales and the West Midlands: 1. Evaluation of immunoreactive trypsin test.
    Ryley HC; Deam SM; Williams J; Alfaham M; Weller PH; Goodchild MC; Carter RA; Bradley D; Dodge JA
    J Clin Pathol; 1988 Jul; 41(7):726-9. PubMed ID: 3410967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of stored dried blood spots from children with cystic fibrosis and matched controls to assess the performance of a proposed newborn screening protocol in Switzerland.
    Barben J; Gallati S; Fingerhut R; Schoeni MH; Baumgartner MR; Torresani T;
    J Cyst Fibros; 2012 Jul; 11(4):332-6. PubMed ID: 22300503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoreactive trypsin screening for cystic fibrosis.
    Borgström A; Sveger T; Lindberg T; Kollberg H; Larsson A
    Acta Paediatr Scand; 1982 Jul; 71(4):621-4. PubMed ID: 7136678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.